Brief: Unity Biotechnology Q4 Operating Income USD -9.991 Million
07/03/2025 21:30
Mar 07 (Reuters) - Unity Biotechnology Q4 operating expenses USD 9.991 million. Q4 net income USD -8.44 million Q4 basic EPS USD -0.5
Recent news on Unity Biotechnology
See all newsU.S. STOCKS ON THE MOVE-Eve Holding, Magnite, EHang Holdings
U.S. STOCKS ON THE MOVE-Lamb Weston, Robinhood, Eve Holding
Unity Biotechnology slips as co faces Nasdaq delisting, plans dissolution
Brief: Unity Biotechnology Inc - Board Approves Plan Of Dissolution - SEC Filing
Brief: UNITY Biotechnology Estimates $3.7 Million Expenses For Reduction In Force